US FDA Approves Gilead’s Once-Daily Combination Pill for HIV Treatment

US FDA approves Gilead’s once-daily combination pill for HIV treatment

Aug 27 (Reuters) - The U.S. Food and Drug Administration has approved Gilead ​Sciences' once-daily oral combination ‌pill for treatment of adults whose HIV infection has already been reduced to very ‌low ​levels, the ⁠company said on ⁠Thursday. The dru...

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens

FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug 27, 2026-

Gilead gets another HIV treatment approval, extending lenacapavir's dominance

Gilead Sciences' HIV treatment arsenal is getting bigger. The leading drugmaker in the four-decade epidemic gained another FDA stamp of approval on Thursday. This time, Gilead will market ...